GTR 120058234

Request For Quotation Purchase Of Medicines And Other Medical Products, , Tel. 87172 564008

ICB — International Competitive Bid Closes Nov 03, 2026 — 1 days left Central Asia
Tender Information
GTR Reference
120058234
Tendering Authority
Subscribe to view
Tender No
17890141
Financer Name
Self-Funded
Work Title
Request For Quotation Purchase Of Medicines And Other Medical Products, , Tel. 87172 564008
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Central Asia
Political Region
Commonwealth of Independent States, CIS
Last Date of Bid Submission
03-11-2026 1 days left
Work Detail
Nebulizer Solution, Not Less Than 5 Mg/Ml. Composition1 Ml Of Solution Containsactive Substance – Salbutamol 5 Mg (Equivalent To Salbutamol Sulfate),Excipients: Benzalkonium Chloride Solution, Diluted Sulfuric Acid, Purified Water., Solution For Injection, Not Less Than 0.5 Mg/Ml, 1 Ml. No. 10. Composition Of The Medicinal Product1 Ml Of The Drug Containsactive Substance – Neostigmine Methyl Sulfate (Prozerin) 0.5 Mg,Excipients - Water For Injection., Solution For Injection Not Less Than 1 Mg/Ml. No. 10. Ampoule. Composition Of The Medicinal Product1 Ml Of Solution Containsactive Substance - Atropine Sulfate 1.0 Mg;Excipients: 0.1 M Hydrochloric Acid, Water For Injection., Calcium Chloride At Least 10% 5 Ml In Ampoules. Composition Of The Medicinal Productone Ml Of Solution Containsactive Substance - Calcium Chloride Hexahydrate (In Terms Of Calcium Chloride 50.7 Mg) 100 Mg,Excipients: Diluted Hydrochloric Acid, Water For Injection., Hydrocortisone Ointment External, At Least 1% 10 G Ointment In A Tube. Composition Of The Medicinal Product100 G Ointment Containsactive Substance - Hydrocortisone Acetate, 1.0 G;Excipients: Methyl Parahydroxybenzoate (Nipagin), Propyl Parahydroxybenzoate (Nipazole), Petrolatum, Stearic Acid, Anhydrous Lanolin, Pentaerythrityl Dioleate (Pentol), Purified Water, Gel/Ointment For External Use, At Least 20G. In The Tube. Composition Of The Medicinal Product100 G Of Gel Containsactive Ingredients: Liquid Onion Extract ((Allium Cepa L., Bulbus (0.16: 1) Extractant: Aqueous-Alcoholic Solution Of Ethanol 96%) 10.00 G, Sodium Heparin (125 U/Mg) 0.04 G, Allantoin 1.00 Gexcipients: Sorbic Acid (E200), Methyl Parahydroxybenzoate (E218), Xanthan Gum, Polyethylene Glycol 200, Perfume Oil Aroma 30263773 Rose (With Citronellol, Geraniol, Benzyl Alcohol, Citrate And Linalool), Purified Water., Drops For Oral Administration, Bottle Packaging Of At Least 100 Ml. Pharmacotherapeutic Groupgenitourinary System And Sex Hormones. Urological Drugs. Urological Drugs Are Different. Composition Of The Medicinal Product100 G Of The Drug Containsactive Substance: 29 G Of Aqueous-Alcoholic Extract From The Medicinalvegetable Raw Materials:Centaury Grass 0.6 Glovage Medicinal Roots 0.6 Grosemary Leaves 0.6 Gexcipients: Ethanol 59%, Purified Water. The Product And Shelf Life Must Comply With All Standards And Requirements Of Regulatory Documents For Monitoring The Quality And Safety Of Medicines And Medical Devices., Cream At Least 2% 40G. Composition Of The Medicinal Productone Gram Of The Drug Containsactive Substance – Silver Sulfathiazole 20.0 Mgexcipients: Cetostearyl Alcohol, Liquid Paraffin, White Petrolatum, Sodium Lauryl Sulfate, Glycerin, Methyl Parahydroxybenzoate, Propyl Parahydroxybenzoate, Potassium Dihydrogen Phosphate, Sodium Hydrogen Phosphate, Water For Injection. The Product And Shelf Life Must Comply With All Standards And Requirements Of Regulatory Documents For Monitoring The Quality And Safety Of Medicines And Medical Devices., Pasta At Least 30G. Composition Of The Medicinal Product100 G Of The Drug Containsactive Substance – Zinc Oxide – 25 Gexcipients – Potato Starch, Medical Vaseline. The Product And Shelf Life Must Comply With All Standards And Requirements Of Regulatory Documents For Monitoring The Quality And Safety Of Medicines And Medical Devices., Tablets, No Less Than No. 100. Composition Of The Medicinal Productone Tablet Containsactive Substance – Ethamsylate 250 Mg,Excipients: Anhydrous Citric Acid, Corn Starch, Lactose Monohydrate, Povidone, Magnesium Stearate, Ethanol 96%*. The Product And Shelf Life Must Comply With All Standards And Requirements Of Regulatory Documents For Monitoring The Quality And Safety Of Medicines And Medical Devices., Powder For The Preparation Of A Solution For Intravenous And Intramuscular Administration, Powder For Injection, At Least 1 G No. 1. Anti-Infective Drugs For Systemic Use. Antibacterial Drugs For Systemic Use. Beta-Lactam Antibacterial Drugs Are Different. Third Generation Cephalosporins. Ceftriaxone. The Product And Shelf Life Must Comply With All Standards And Requirements Of Regulatory Documents For Monitoring The Quality And Safety Of Medicines And Medical Devices., Tablets, Packaging Of At Least 50 Mg No. 30. One Tablet Containsactive Substance: Furagin 50 Mg,Excipients: Lactose Monohydrate, Pregelatinized Starch, Sugar, Polysorbate 80 (Tween 80), Stearic Acid. The Product And Shelf Life Must Comply With All Standards And Requirements Of Regulatory Documents For Monitoring The Quality And Safety Of Medicines And Medical Devices., Syrup, Packaging Of At Least 100 Ml. Composition5 Ml Of Syrup Contains:Active Substances:Tribulus Terrestris Extract 91 Mgboerhavia Spreading Roots Extract 67Mgsaxifraga Ligulate Roots Extract 53 Mgalmond Ground Tuber Extract 42 Mgasparagus Racemosus Root Extract 21 Mgfire Bean Seed Extract 21Mg Vetiver Root Extract 21 Mg Turmeric Zedoaria Rhizome Extract 14Mgtrikatu Rhizomes And Fruits Extract 20 Mgpotassium Nitrate 42.5 Mgammonium Chloride 2.5 Mgpotassium Carbonate 5Mgsodium Chloride 50 Mgexcipients: Sugar S30, Sorbitol 70%, Sun 528 Flavor, Citric Acid, Sodium Citrate, Sodium Methyl Parahydroxybenzoate, Sodium Propyl Parahydroxybenzoate, Sodium Benzoate, Qs Purified Water. The Product And Shelf Life Must Comply With All Standards And Requirements Of Regulatory Documents For Monitoring The Quality And Safety Of Medicines And Medical Devices, Lyophilisate For The Preparation Of Solution For Injection And Inhalation, Complete With Solvent, Packaging Of At Least 500 Mg No. 3. Composition Of The Medicinal Productone Bottle Containsactive Substance - Thiamphenicol Glycinate Acetylcysteinate 810 Mg (Equivalent To Thiamphenicol 500 Mg),Excipient – Disodium Edetate.Solvent – ​​Water For Injection. The Product And Shelf Life Must Comply With All Standards And Requirements Of Regulatory Documents For Monitoring The Quality And Safety Of Medicines And Medical Devices., Solution For Inhalation, Bottle Of At Least 20 Ml. Pharmacotherapeutic Group. Respiratory System. Drugs For The Treatment Of Obstructive Airway Diseases. Adrenergic, Inhalation. Adrenergic Drugs In Combination With Anticholinergics, Including Triple Combinations With Corticosteroids. Fenoterol And Ipratropium Bromide. The Product And Shelf Life Must Comply With All Standards And Requirements Of Regulatory Documents For Monitoring The Quality And Safety Of Medicines And Medical Devices., Solution For Oral Administration, Bottle Packaging Of At Least 4 Mg/5 Ml. 100 Ml Of Solution Contains:Active Ingredient – Bromhexine Hydrochloride 0.080 Gexcipients:Maltitol, Benzoic Acid, Apricot Flavor Powder, Anhydrous Citric Acid, Purified Water. The Product And Shelf Life Must Comply With All Standards And Requirements Of Regulatory Documents For Monitoring The Quality And Safety Of Medicines And Medical Devices., Solution, Bottle Packaging Not Less Than 7.5 Mg/Ml, 100 Ml. 1 Ml Of The Drug Containsactive Substance - Ambroxol Hydrochloride 7.5 Mg,Excipients – Potassium Sorbate, Hydrochloric Acid 25% (For Ph Correction), Purified Water. The Product And Shelf Life Must Comply With All Standards And Requirements Of Regulatory Documents For Monitoring The Quality And Safety Of Medicines And Medical Devices., Powder For The Preparation Of Solution For Oral Administration, Packaging Of At Least 200 Mg No. 50. 1 Sachet Contains 3 G Of Powderactive Substance - Acetylcysteine 200.00 Mgexcipients: Sucrose, Ascorbic Acid, Saccharin, Dry Orange Flavor**(**- Orange Flavor Essence 11.1%, Dextrose Anhydride 82.7%, Lactose 6.2%). The Product And Shelf Life Must Comply With All Standards And Requirements Of Regulatory Documents For Monitoring The Quality And Safety Of Medicines And Medical Devices., Suspension For Oral Use, Packaging Not Less Than 2.4% 100 Ml. Composition100 Ml Of Suspension Containactive Substance – Paracetamol 2.4 G,Excipients - Sorbitol, Distilled Glycyrin, Carbomer, Methylparaben, Propylparaben, Citric Acid, Sodium Citrate, Sodium Saccharinate, Food Flavoring, Red Sour Dye 2C, Purified Waterthe Drug Does Not Contain Alcohol. The Product And Shelf Life Must Comply With All Standards And Requirements Of Regulatory Documents For Monitoring The Quality And Safety Of Medicines And Medical Devices., Capsules, Packaging Of At Least 200 Mg No. 10. Composition Of The Medicinal Productone Capsule Containsactive Substance – Ibuprofen 200 Mg,Excipients: Macrogol 600, Potassium Hydroxide, Purified Water,Shell: Liquid Sorbitol, Non-Crystallizing, Liquid Maltitol, Gelatin. The Product And Shelf Life Must Comply With All Standards And Requirements Of Regulatory Documents For Monitoring The Quality And Safety Of Medicines And Medical Devices.
Key Value
Tender Value
5,562,398 - KZT
Tender Documents
Global Tender Document
e66a33af-2f9a-4445-a18c-7253e10e0fd8.html
Attachments
Additional Details Available on Click
  • Tendering Authority
  • Publication Document (Tender Document / Tender Notice)
Disclaimer

We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.

Tell us about your Product / Services,

We will Find Tenders for you